Company · CIK 1646102

# Theravance Biopharma Antibiotics, Inc.

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

| CIK | [1646102](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001646102) (SEC EDGAR) |
| --- | --- |
| Incorporated in | E9 |
| Business address | Cayman Islands |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-205275-06 | Shelf Effective | 2015-06-26 | 2015-07-16 | 2 |

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2015-07-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1646102/999999999515001956/9999999995-15-001956-index.htm) Declared effective | 333-205275-06 | 9999999995-15-001956 |
| 2015-06-26 | [S-3](https://www.sec.gov/Archives/edgar/data/1646102/000104746915005813/0001047469-15-005813-index.htm) Shelf registered | 333-205275-06 | 0001047469-15-005813 |

[All filings of this company](https://equitycapital.markets/filings?cik=1646102) · [CSV](https://equitycapital.markets/filings.csv?cik=1646102)

---
Source page: https://equitycapital.markets/company/1646102 · Data: U.S. SEC EDGAR · CC BY 4.0